"10.1371_journal.pone.0065797","plos one","2013-06-06T00:00:00Z","Susan R Heimer; David J Evans; James J Mun; Michael E Stern; Suzanne M J Fleiszig","School of Optometry, University of California, Berkeley, California, United States of America; College of Pharmacy, Touro University-California, Vallejo, California, United States of America; Allergan Inc., Irvine, California, United States of America; Graduate Groups in Vision Science, Microbiology, and Infectious Diseases and Immunity, University of California, Berkeley, California, United States of America","Conceived and designed the experiments: SF DE MS SH. Performed the experiments: SH JM. Analyzed the data: SH DE SF. Wrote the paper: SH DE MS SF.","The authors have the following interests. Dr. Fleiszig is a PLOS ONE Academic Editor. Dr. Fleiszig is a paid consultant with Allergan Inc. However, that activity is unrelated to the work presented in the manuscript. Dr. Stern is a paid employee of Allergan Inc. Drs. Evans and Fleiszig are co-inventors on a US patent #7,332,470 B2 held by the University of California, Berkeley entitled “Methods and Compositions for Treating Ocular Disease” which involves possible use of collectins, e.g. SP-D in this regard. The authors have not received income from this unlicensed patent. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","06","Susan R Heimer","SRH",5,TRUE,4,2,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
